References
- Bielack SS, Kempf-Bielack B, Delling G, Exner GU, Flege S, Helmke K, et al. Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols. J Clin Oncol 2002;20:776–90.
- Kim MS, Lee SY, Cho WH, Song WS, Koh JS, Lee JA, et al. Initial tumor size predicts histologic response and survival in localized osteosarcoma patients. J Surg Oncol 2008;97:456–61.
- Provisor AJ, Ettinger LJ, Nachman JB, Krailo MD, Makley JT, Yunis EJ, et al. Treatment of nonmetastatic osteosarcoma of the extremity with preoperative and postoperative chemotherapy: a report from the Children's Cancer Group. J Clin Oncol 1997;15:76–84.
- Whelan JS, Jinks RC, McTiernan A, Sydes MR, Hook JM, Trani L, et al. Survival from high-grade localised extremity osteosarcoma: combined results and prognostic factors from three European Osteosarcoma Intergroup randomised controlled trials. Ann Oncol 2012;23:1607–16.
- Iwata S, Nakamura T, Gaston CL, Carter SR, Tillman RM, Abudu A, et al. Diaphyseal osteosarcomas have distinct clinical features from metaphyseal osteosarcomas. Eur J Surg Oncol 2014;40:1095–100.
- Jeon DG, Song WS, Cho WH, Kong CB, Cho SH. Proximal tumor location and fluid-fluid levels on MRI predict resistance to chemotherapy in Stage IIB osteosarcoma. Clin Orthop Relat Res 2014;472:1911–20.
- Cho WH, Song WS, Jeon DG, Kong CB, Kim MS, Lee JA, et al. Differential presentations, clinical courses, and survivals of osteosarcomas of the proximal humerus over other extremity locations. Ann Surg Oncol 2010;17:702–8.
- Picci P, Bacci G, Campanacci M, Gasparini M, Pilotti S, Cerasoli S, et al. Histologic evaluation of necrosis in osteosarcoma induced by chemotherapy. Regional mapping of viable and nonviable tumor. Cancer 1985;56:1515–21.
- Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A. AJCC Cancer Staging Manual. 7th ed. New York: Springer; 2010. 648 p.
- Czerniak B. Osteosarcoma. Dorfman and Czerniak's Bone Tumors. 2nd ed. Philadelphia, PA: Elsevier; 2016.
- Kim MS, Lee SY, Cho WH, Song WS, Koh JS, Lee JA, et al. An examination of the efficacy of the 8 cm maximal tumor diameter cutoff for the subdivision of AJCC Stage II osteosarcoma patients. J Surg Oncol 2008;98:427–31.